Overview Markets Watchlist

© 2026 IR SuperintelMethodology Contact

Karyopharm Therapeutics Inc

CUSIP: 48576U906 | 8 institutional holders

Quarters

Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023

Compare Detailed Historical Funds Options 13D/13G Peers Targeting Trading Summary Profile